ScreenerHero

SLBT SL Science Holding Limited

NAS · US · Healthcare · Biotechnology · sl-bio.com
1.510USD-0.66%Mkt Cap: 846.75M $P/E: —

SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate se…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap846.75M USD
Enterprise Value2.52M USD
Revenue (TTM)3.27M USD
Gross Profit775.06K USD
Net Income (TTM)-3.82M USD
Revenue/Share0.89 USD
Last Price1.510 USD
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.10
EV/Revenue0.77
P/S260.65
P/B1.18
EPS (TTM)-0.01
EPS (Forward)—
52W Range
1.4201% of range14.50
52W High14.50 USD
52W Low1.420 USD
Profitability
Gross Margin35.27%
Oper. Margin-142.55%
EBITDA Margin-69.87%
Profit Margin-173.85%
ROE-167.25%
ROA-135.59%
Growth
Revenue Growth-7.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.91M USD
CapEx (TTM)319.69K USD
FCF Margin—
FCF Yield—
Net Debt-3.07M USD
Net Debt/EBITDA1.34
Balance Sheet
Debt/Equity0.09
Current Ratio4.90
Quick Ratio3.84
Book Value/Sh1.29 USD
Cash/Share0.92 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.560.76M
Float—
Insiders59.55%
Institutions0.29%
Short Interest
Short Ratio0.4d
Short % Float0.01%
Short % Out.0.00%
Shares Short26.77K
Short (prev mo.)31.58K
Technical
SMA 502.408 (-37.3%)
SMA 2006.960 (-78.3%)
Beta—
S&P 52W Chg15.78%
Avg Vol (30d)89.40K
Avg Vol (10d)93.14K
Technical Indicators
RSI (14)32.9
MACD-0.2804
MACD Signal-0.3010
MACD Hist.+0.0206
BB Upper2.127 USD
BB Middle1.749 USD
BB Lower1.371 USD
BB Width43.27%
ATR (14)0.1959 USD
Vol Ratio (20d)0.66x